Our results presented here showed that levels of deacetylation-category genes remained unchanged (p > 0.188) in the aged HD samples (Fig. 4), thereby supporting the possible use of HDAC inhibitors to increase histone acetylation in HD patients. Here, HDAC9 is linked to Huntington disease.